ESC 365 - APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

ESC Premium Access

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Session: Late Breaking Science in Atrial Fibrillation 2

Topic: Prevention

Speaker: Professor P. Steg (Paris, FR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

66 presentations

10 followers

4 more presentations in this session

Integrated management of atrial fibrillation in primary care: the ALL-IN cluster randomised trial

Speaker: Ms C. Van Den Dries (Utrecht, NL)

Opportunistic screening for atrial fibrillation versus routine care in older persons in the community: findings from a dutch nationwide primary care-based cluster randomised clinical trial

Speaker: Mr S. Uittenbogaart (Amsterdam, NL)

A home-based education and learning program for atrial fibrillation: the HELP-AF study

Speaker: Professor P. Sanders (Adelaide, AU)

Randomised clinical trial of nurse-led integrated care for atrial fibrillation, a comparison with care as usual provided by the cardiologist

Speaker: Ms P. Wijtvliet (Maastricht, NL) Professor H. Crijns (Maastricht, NL)

Access the full session

Late Breaking Science in Atrial Fibrillation 2

Speakers: Professor P. Steg, Ms C. Van Den Dries, Mr S. Uittenbogaart, Professor P. Sanders, Ms P. Wijtvliet...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources